Latest filing published 10 Mar 2026 for Aurinia Pharmaceuticals Inc., €100k.
Filing timeline
BuySaleInsider track record
Greg Keenan: trading record in brief
Greg Keenan appears in our data through filings on Aurinia Pharmaceuticals Inc. shares, published by SEC (Form 4). The record holds 7 filings, for trades running from 28 February 2025 to 6 March 2026.
Every open-market trade on record is a sale: 3 sales worth €341k. The rest of the record consists of 4 share grants.
The newest entry dates from 10 March 2026: a share grant of €100k, in Aurinia Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Greg Keenan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,069 shares@ US$14.3220.4% of flowCommon StockSEC:0001600620-26-000024:0
- 40,586 shares0Common StockSEC:0001600620-26-000020:0
- 11,552 shares@ US$14.5329.0% of flowCommon StockSEC:0002044006-26-000002:0
- 20,000 shares@ US$10.5037.6% of flowCommon StockSEC:0001600620-25-000095:0
- 8,305 shares@ US$8.2313.0% of flowCommon StockSEC:0001600620-25-000026:0
- 62,583 shares0Common StockSEC:0001600620-25-000022:0
6 of 6 declarations
